Could tiny broccoli plants help obese breast cancer survivors?

NCT ID NCT07032545

Recruiting now Knowledge-focused Sponsor: University of Maryland, Baltimore Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether eating one cup of broccoli microgreens daily for two weeks is practical and beneficial for obese breast cancer survivors. Researchers will measure how well participants stick to the diet and track changes in body fat, blood sugar, and inflammation. The goal is to see if this simple food can improve health and lower the risk of cancer returning.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Broccoli microgreens (BMG)
What this could lead to: If successful, this could point toward a simple dietary strategy to reduce cancer recurrence risk in obese breast cancer survivors.
What could go wrong: This is a very small, early feasibility study with only 24 participants and no control group, so results may not apply broadly. The 2-week intervention is too short to measure long-term health effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm Obesity obesity disorder Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER SURVIVORSHIP OBESITY AND OVERWEIGHT

Contacts and locations

Locations

Breast Evaluation and Treatment Program, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
RECRUITING

Baltimore, Maryland, 21201, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.